PLATEAU-A Ti Anterior Lumbar Spacer System receives US FDA clearance

2046

Life Spine has announced that it has received clearance from the US Food and Drug Administration (FDA) to market the PLATEAU-A Ti Anterior Lumbar Spacer System.

“With the increased usage of anterior column reconstruction, PLATEAU-A Ti fills an important portfolio gap,” said Rich Mueller, chief operating officer for Life Spine.

PLATEAU-A Ti Anterior Lumbar Spacer System can be used for anterior fusion procedures and multiple footprint sizes are available in various heights to accommodate individual patient anatomies and pathologies to promote fusion.

The key features and benefits of the device include:

  • Large, open graft windows for maximum visibility and bone graft containment
  • Osseo-Loc Surface Treatment Technology
  • Chamfered leading edge to ease implant insertion

LEAVE A REPLY

Please enter your comment!
Please enter your name here